Clinical Trials Directory

Trials / Completed

CompletedNCT03663309

Assessment of Adherence to Gluten Free Diet in Children and Adolescents by Detection of Gluten in Faecal Samples.

Assessment of Adherence to Gluten Free Diet in Children and Adolescents by Detection of Gluten Immunogenic Peptides in Faecal Samples and Nutritional Assessment. Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
194 (actual)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
2 Years – 17 Years
Healthy volunteers

Summary

To assess the adherence to gluten free diet by measuring faecal and urinary gluten immunogenic peptides (GIP). This will provide an objective measure for adherence.

Detailed description

The adherence to the GFD can be assessed through a dietary interview performed by a registered dietitian or patient self-reports, mucosal healing, assessed by a small bowel biopsy or CD serological screening tests showing decreasing levels of antibodies. However, none of these methods offer an accurate measure of dietary compliance. A novel method to monitor the adherence to the GFD by detection of immune-dominant gluten peptides in human faeces or urine using the anti-α -gliadin G12 antibody was described recently in the literature. Gluten peptides, in particular peptides equivalent to the immunogenic - α -gliadin-33-mer peptide, are resistant to gastrointestinal digestion and that ensures a significant amount of the ingested gluten is excreted in faeces. Consequently, recovery of detectable amounts of the immunogenic fraction in faeces or urine indicates that gluten has passed through the digestive tract, and in the case of urine was absorbed, and, therefore, that gluten has been consumed .

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTdetecting Gluten peptides in faecal and urine samplesAt each visit patient will: * Bring 4-day food diary (attached) * Fill symptoms and complaints questionnaire (attached) * Provide 24 h diet recall in case a food diary absents * Fill Biagi score questionnaire (attached) * Perform blood test of TTG * Provide stool and urine samples

Timeline

Start date
2018-06-19
Primary completion
2021-06-03
Completion
2021-06-03
First posted
2018-09-10
Last updated
2021-10-01

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03663309. Inclusion in this directory is not an endorsement.